Cargando...

Preclinical approaches in chronic myeloid leukemia: from cells to systems

Advances in the design of targeted therapies for the treatment of chronic myeloid leukemia (CML) have transformed the prognosis for patients diagnosed with this disease. However, leukemic stem cell persistence, drug intolerance, drug resistance, and advanced-phase disease represent unmet clinical ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Exp Hematol
Autores principales: Clarke, Cassie J., Holyoake, Tessa L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science Inc 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333535/
https://ncbi.nlm.nih.gov/pubmed/28017647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.11.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!